Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06431022 · ClinicalTrials.gov registry record · NA

Web-administered STAIR for Patients on Behavioral Health Waitlists

A NA study of Post Traumatic Stress Disorder, sponsored by Boston Medical Center.

Active
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06431022: Active NA study of Post Traumatic Stress Disorder, sponsored by Boston Medical Center.

NCT06431022 is a NA study of Post Traumatic Stress Disorder that is active but no longer recruiting, run by Boston Medical Center. The registered enrollment target is 70 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06431022, a NA study of Post Traumatic Stress Disorder, is active but no longer recruiting, sponsored by Boston Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

Posttraumatic stress disorder (PTSD) is a significant public health challenge with population prevalence rates in the US between 6.1 to 9.2%. There are large racial and socioeconomic inequities in access to PTSD treatment, as up to half (30-50%) of patients in safety net clinical settings meet criteria for PTSD, yet only 13% receive any behavioral health treatment. Workforce shortages are one major barrier to accessing care. Additional barriers to care can include heightened mental health stigma and mistrust of health services. Digital mental health interventions (DMHIs) may be suitable within the continuum of care for PTSD in hospital settings, given their potential for rapid-access, scalability, and the high acceptability of DMHI among individuals with high stigma and social needs. Among the available DMHIs for PTSD, the investigators have selected web-administered Skills Training in Affective and Interpersonal Regulation (webSTAIR), based on emerging scientific evidence and a close collaboration with Boston Medical Center (BMC) users (patients and providers) in a previous pilot study in primary care. The aim of this randomized study is to implement webSTAIR at BMC in the Recovery from Stress and Trauma through Outpatient Care, Research, and Education (RESTORE) Center's subspecialty clinic.

Primary Outcome

The recruitment rate will be calculated by dividing the number of participants by the total number of eligible participants.

Interventions

  • BEHAVIORAL webSTAIR
  • BEHAVIORAL CHW coaching

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-11-15
Est. Completion 2026-05
Phase NA
Boston Medical Center

253 total trials

What the registry record for NCT06431022 still lists

NCT06431022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which webSTAIR is the first listed.

NCT06431022 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06431022 about?

NCT06431022 is a clinical study titled "Web-administered STAIR for Patients on Behavioral Health Waitlists". Posttraumatic stress disorder (PTSD) is a significant public health challenge with population prevalence rates in the US between 6.1 to 9.2%. There are large racial and socioeconomic inequities in access to PTSD treatment, as up to half (30-50%) of patients in safety net clinical settings meet crite...

What is the current status of trial NCT06431022?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-11-15. Estimated completion is 2026-05.

What conditions does trial NCT06431022 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT06431022?

The interventions under investigation include: webSTAIR (BEHAVIORAL), CHW coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT06431022?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06431022 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06431022's enrollment target sits among peer trials

70 152nd of 262 higher than 110 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06431022, the US trial registry maintained by the National Library of Medicine. NCT06431022 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.